INTO

Accelerating inhalation development.

DFE Pharma, Sterling and Harro Höfliger announce the launch of a new alliance under the name of INTO™

Strategic collaborations have long played an instrumental role in the development of complex inhalation products. When well executed, they can have exponential benefits on pharmaceutical companies, patients, and society. With this common purpose and vision DFE Pharma, Sterling and Harro Höfliger have entered a unique cooperation in the field of respiratory medicine development. The alliance aims to leverage the combined successful experience of the INTO team in supporting pharmaceutical companies and their respiratory product development. INTO is a combined service offering collective accountability increasing efficiency and effectiveness and making complex respiratory drug product development simpler, faster, economic, and easier to manage by offering a co-ordinated and aligned suite of services in one team, no gaps, everyone aligned and focused on meeting the clients' targets, together. Enhanced Product development leveraging a unified set of skills and consolidated expertise.

Strategic collaborations have long played an instrumental role in the development of complex inhalation products. When well executed, they can have exponential benefits on pharmaceutical companies, patients, and society. With this common purpose and vision DFE Pharma, Sterling and Harro Höfliger have entered a unique cooperation in the field of respiratory medicine development. The alliance aims to leverage the combined successful experience of the INTO team in supporting pharmaceutical companies and their respiratory product development. INTO is a combined service offering collective accountability increasing efficiency and effectiveness and making complex respiratory drug product development simpler, faster, economic, and easier to manage by offering a co-ordinated and aligned suite of services in one team, no gaps, everyone aligned and focused on meeting the clients' targets, together. Enhanced Product development leveraging a unified set of skills and consolidated expertise.

#InhalationTogether

About DFE Pharma GmbH & Co. KG

DFE Pharma is a leading excipient solution provider in the field of Inhalation. DFE Pharma offers the pharmaceutical industry the most optimal solution for the development of their Dry Powder Inhalation formulations. DFE Pharma have been partnering with pharmaceutical companies developing drugs for pulmonary delivery for many years. With a wide range of inhalation lactose grades and the option to customize DFE Pharma is able to meet specific customer needs. DFE Pharma expertise and three dedicated inhalation production sites will provide a unique starting point for any advanced pharmaceutical application.

DFE Pharma is a leading excipient solution provider in the field of Inhalation. DFE Pharma offers the pharmaceutical industry the most optimal solution for the development of their Dry Powder Inhalation formulations. DFE Pharma have been partnering with pharmaceutical companies developing drugs for pulmonary delivery for many years. With a wide range of inhalation lactose grades and the option to customize DFE Pharma is able to meet specific customer needs. DFE Pharma expertise and three dedicated inhalation production sites will provide a unique starting point for any advanced pharmaceutical application.

About Sterling S.p.A.

Sterling founded in 1976 is a leading manufacturer of globally approved APIs with class leading facilities in Italy and Malta. Sterling delivers cost-efficient synthesis, process development, solid state science, material characterisation, commercial manufacturing and life-cycle management solutions and has a proven capability to develop APIs for Respiratory sector (Rx & Gx) used in pMDI, capsule and complex DPI products. For more than 30 years Sterling has partnered with clients and supported successful complex inhalation programs providing advanced solutions for customers and in doing so supporting the world's population in the delivery of Respiratory Medicines.

Sterling founded in 1976 is a leading manufacturer of globally approved APIs with class leading facilities in Italy and Malta. Sterling delivers cost-efficient synthesis, process development, solid state science, material characterisation, commercial manufacturing and life-cycle management solutions and has a proven capability to develop APIs for Respiratory sector (Rx & Gx) used in pMDI, capsule and complex DPI products. For more than 30 years Sterling has partnered with clients and supported successful complex inhalation programs providing advanced solutions for customers and in doing so supporting the world's population in the delivery of Respiratory Medicines.

About Harro Höfliger Verpackungsmaschinen GmbH

Harro Höfliger Harro Höfliger develops and manufactures production and packaging equipment for customers around the world. In the inhalation area, Harro Höfliger is providing the ideal dosing technology for filling powder into dry powder inhalers (DPI). The processes are designed to manufacture blisters, capsules, disks, cartridges or reservoirs DPI closure systems. Harro Höfliger supports customers every step of the product lifecycle phase, offering machine technology from the laboratory level to production of test samples to high-volume commercial manufacturing. Go and visit INTO website! www.intoinhalation.com

Harro Höfliger Harro Höfliger develops and manufactures production and packaging equipment for customers around the world. In the inhalation area, Harro Höfliger is providing the ideal dosing technology for filling powder into dry powder inhalers (DPI). The processes are designed to manufacture blisters, capsules, disks, cartridges or reservoirs DPI closure systems. Harro Höfliger supports customers every step of the product lifecycle phase, offering machine technology from the laboratory level to production of test samples to high-volume commercial manufacturing. Go and visit INTO website! www.intoinhalation.com